Transcription of Interleukin-8: How Altered Regulation Can Affect.pdf (169.12 kB)
0/0

Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease.

Download (169.12 kB)
journal contribution
posted on 22.11.2019 by Karim Jundi, Catherine M. Greene

Interleukin-8 (IL-8) is a neutrophil chemokine that is encoded on the CXCL8 gene. Normally CXCL8 expression is repressed due to histone deacetylation, octamer-1 binding to the promoter and the inhibitory effect of nuclear factor-κB repressing factor (NRF). However, in response to a suitable stimulus, the human CXCL8 gene undergoes transcription due to its inducible promoter that is regulated by the transcription factors nuclear factor-κB (NF-κB), activating protein (AP-1), CAAT/enhancer-binding protein β (C/EBPβ, also known as NF-IL-6), C/EBP homologous protein (CHOP) and cAMP response element binding protein (CREB). CXCL8 mRNA is then stabilised by the activity of p38 mitogen-activated protein kinase (p38 MAPK). Cystic fibrosis (CF) lung disease is characterised by a neutrophil-dominated airway inflammatory response. A major factor contributing to the large number of neutrophils is the higher than normal levels of IL-8 that are present within the CF lung. Infection and inflammation, together with intrinsic alterations in CF airway cells are responsible for the abnormally high intrapulmonary levels of IL-8. Strategies to inhibit aberrantly high CXCL8 expression hold therapeutic potential for CF lung disease.

Funding

Science Foundation Ireland, National Children’s Research Centre, Royal College of Surgeons in Ireland, European Respiratory Society.

History

Comments

The original article is available at http://www.mdpi.com/

Published Citation

Jundi K, Greene CM. Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease. Biomolecules. 2015;5(3):1386-98.

Publication Date

01/07/2015

Publisher

MDPI AG, Basel, Switzerland

PubMed ID

26140537

Exports

Logo branding

Categories

Exports